← Leaderboards
Elebeoba E May
Sandia Corp-Sandia National Laboratories
$746,288
Attributed
$746,288
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $158.2K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$746,288 · 1
By mechanism
K25$746,288 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoInfancyBaseInfectionAnimal ModelBiochemical PathwayBiologicalCommunicable DiseasesComputing MethodologiesBiologyCandidate Disease GeneEducational WorkshopEvaluationFundingGene ExpressionGene Expression Microarray AnalysisGenerationsGenesGeneticGenetic AnalysisGenomeDesignImmune ResponseKnock-Out
Grant awards (5)
Analyzing the Genetic Basis of Mtb Latency/Reactivation$158,209
K25 · FY2009 · HL · contact PI
Analyzing the Genetic Basis of Mtb Latency/Reactivation$153,601
K25 · FY2008 · HL · contact PI
Analyzing the Genetic Basis of Mtb Latency/Reactivation$149,127
K25 · FY2007 · HL · contact PI
Analyzing the Genetic Basis of Mtb Latency/Reactivation$144,784
K25 · FY2006 · HL · contact PI
Analyzing the Genetic Basis of Mtb Latency/Reactivation$140,567
K25 · FY2005 · HL